vidarabine has been researched along with eye in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (87.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bowman, K; Gangarosa, LP; Green, K; Hill, JM; Hull, DS; Park, NH; Tuggle, CL | 1 |
Geary, PA; Kinkel, A; North, RD; Pavan-Langston, D | 1 |
O'Brien, WJ | 1 |
Meyers-Elliott, R; Niizawa, JM; Yoshizumi, MO | 1 |
Kaufman, HE; Leader, B; Zimmerman, TJ | 1 |
Fiscella, R; Greenberg, D; Palacio, M; Peyman, GA; Pulido, JS; Stelmack, T | 1 |
Colin, J | 1 |
Cheng, Q; Lee, DA; Shapourifar-Tehrani, S | 1 |
2 review(s) available for vidarabine and eye
Article | Year |
---|---|
Advances in ocular pharmacology.
Topics: Animals; Cannabis; Carbachol; Cytochalasin B; Epinephrine; Eye; Eye Diseases; Glaucoma; Humans; Idoxuridine; Interferons; Intraocular Pressure; Keratitis; Membranes, Artificial; Pharmaceutical Preparations; Timolol; Trifluridine; Vidarabine; Virus Diseases | 1980 |
[Arabinosyladenine in ophthalmology (author's transl)].
Topics: Animals; Clinical Trials as Topic; Cornea; Cricetinae; Drug Evaluation, Preclinical; Eye; Female; Humans; Idoxuridine; Infusions, Parenteral; Keratitis, Dendritic; Male; Microbial Sensitivity Tests; Rabbits; Vidarabine | 1981 |
1 trial(s) available for vidarabine and eye
Article | Year |
---|---|
[Arabinosyladenine in ophthalmology (author's transl)].
Topics: Animals; Clinical Trials as Topic; Cornea; Cricetinae; Drug Evaluation, Preclinical; Eye; Female; Humans; Idoxuridine; Infusions, Parenteral; Keratitis, Dendritic; Male; Microbial Sensitivity Tests; Rabbits; Vidarabine | 1981 |
6 other study(ies) available for vidarabine and eye
Article | Year |
---|---|
Iontophoresis of vidarabine monophosphate into rabbit eyes.
Topics: Adenine; Adenosine; Animals; Aqueous Humor; Cornea; Eye; Hypoxanthines; Iontophoresis; Iris; Lens, Crystalline; Ophthalmic Solutions; Rabbits; Vidarabine | 1978 |
Intraocular penetration of the soluble antiviral, Ara AMP.
Topics: Administration, Topical; Animals; Aqueous Humor; Biological Availability; Conjunctiva; Eye; Humans; Injections, Intravenous; Keratitis, Dendritic; Male; Purine Nucleosides; Rabbits; Solubility; Vidarabine | 1976 |
Therapy with 9-beta-D-arabinofuranosyladenine (ARA-A) and 2'-deoxycoformycin increases the ARA-A content of ocular tissues.
Topics: Animals; Arabinonucleosides; Chromatography; Coformycin; Eye; Keratitis, Dendritic; Pentostatin; Rabbits; Ribonucleosides; Vidarabine | 1986 |
Ocular toxicity of intravitreal vidarabine solubilized in dimethyl sulfoxide.
Topics: Animals; Cells, Cultured; Dimethyl Sulfoxide; Eye; Female; Keratitis, Dendritic; Male; Rabbits; Solubility; Vidarabine; Vitreous Body | 1986 |
Toxicity of intravitreal antiviral drugs.
Topics: Acyclovir; Animals; Dose-Response Relationship, Drug; Eye; Injections; Rabbits; Vidarabine; Vitreous Body | 1984 |
Comparative efficacy of antiviral drugs on human ocular fibroblasts.
Topics: Acyclovir; Amantadine; Antiviral Agents; Cataract; Cell Division; Cell Line; Connective Tissue Cells; Depression, Chemical; Eye; Fibroblasts; Glaucoma; Humans; Vidarabine; Zidovudine | 1995 |